$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$4.25B
Market Cap
-
P/E Ratio
-1.26
EPS
$45.30
52 Week High
$22.97
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Legend Biotech Corporation is a leading clinical-stage biopharmaceutical company focused on developing breakthrough cell therapies, especially in oncology, using its innovative CAR-T cell therapy platform. With a strong pipeline and a commitment to stringent clinical research, the company is strategically addressing critical unmet medical needs, aiming to improve patient outcomes significantly. Strategic partnerships enhance its capabilities, positioning Legend Biotech as an attractive investment opportunity for institutional investors looking to capitalize on advancements in immuno-oncology. As it advances through pivotal clinical trials, the potential for substantial returns in the rapidly evolving biopharmaceutical landscape continues to grow.
LPTX
KIND
IVP
F
WOK
KAVL
ADAP
HOOD
NIO
PFE
NVDA
ASBP
PLTD
AMD
CDE
SNAP
MTSR
TSLA
FI
AVGO
NOK
MSFT
HBAN
CCL
UBER
KO
WULF
SOUN
CNQ
VZ
CLSK
CAN
EOSE
FCX
CGC
INTC
MSTR
IONQ
MU
CX
AMCR
SLB
ITUB
TSLG
PLUG
MDLZ
NKE
JOBY
NVTS
TSM
XOM
ASTS
CPNG
LYFT
SHOT
ZAPP
RXRX
KHC
WRBY
KDP
AUR
VALE
AGNC
ORCL
LPTX
KIND
IVP
F
WOK
KAVL
ADAP
HOOD
NIO
PFE
NVDA
ASBP
PLTD
AMD
CDE
SNAP
MTSR
TSLA
FI
AVGO
NOK
MSFT
HBAN
CCL
UBER
KO
WULF
SOUN
CNQ
VZ
CLSK
CAN
EOSE
FCX
CGC
INTC
MSTR
IONQ
MU
CX
AMCR
SLB
ITUB
TSLG
PLUG
MDLZ
NKE
JOBY
NVTS
TSM
XOM
ASTS
CPNG
LYFT
SHOT
ZAPP
RXRX
KHC
WRBY
KDP
AUR
VALE
AGNC
ORCL